Panacea Index Logo

Command Palette

Search for a command to run...

The neuroprotective role of melatonin in neurological disorders.

Journal of neuroscience research
July 1, 2018
B S Alghamdi
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to review melatonin's neuroprotective role and its involvement in the pathophysiology of neurological disorders such as stroke, Alzheimer's disease, and Parkinson's disease.

Results Summary

The study found that melatonin has a wide-ranging regulatory and neuroprotective role, with potential therapeutic benefits for neurological disorders and no reported side effects. It also indicated disturbed melatonin levels in certain neurological conditions, suggesting its involvement in disease pathophysiology.

Population

Patients with neurological conditions (stroke, Alzheimer's disease, Parkinson's disease)

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (5)
InterventionDirectionEndpointPopulationDosageImpactClaim #
melatonin
neutral
regulatory and neuroprotective role
-
-
has a wide-ranging regulatory and neuroprotective role
#1
melatonin level
neutral
melatonin level
patients with stroke, Alzheimer's disease, and Parkinson's disease
-
disturbed
#2
melatonin
neutral
pathophysiology of stroke, Alzheimer's disease, and Parkinson's disease
-
-
involvement in the pathophysiology
#3
melatonin
neutral
neuroprotection
patients with neurological disorders
-
promising potential therapeutic neuroprotective agent
#4
melatonin
no change
side effects
-
-
no side effects
#5
Abstract

Melatonin is a neurohormone secreted from the pineal gland and has a wide-ranging regulatory and neuroprotective role. It has been reported that melatonin level is disturbed in some neurological conditions such as stroke, Alzheimer's disease, and Parkinson's disease, which indicates its involvement in the pathophysiology of these diseases. Its properties qualify it to be a promising potential therapeutic neuroprotective agent, with no side effects, for some neurological disorders. This review discusses and localizes the effect of melatonin in the pathophysiology of some diseases.

Medical Subject Headings (MeSH)
AnimalsHumansMelatoninNervous System DiseasesNeuroprotectionNeuroprotective Agents
Study Links
Quality Scores
Safety90
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations139
Citations/Year19.9
Relative Citation Ratio7.81
NIH Percentile96.7%
Research Impact Scores
APT Score0.75
Weight Score1.22
Normalized Score0.82
Related Supplements